Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Vamigyn: dysplasia and controls

ABSTRACT: Human vaginal microbiome in cervical dysplasia and healthy controls

PROVIDER: PRJEB72778 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	ERR12719200_1.fastq.gz	Fastqsanger.gz
	ERR12719200_2.fastq.gz	Fastqsanger.gz
	ERR12719300_1.fastq.gz	Fastqsanger.gz
	ERR12719300_2.fastq.gz	Fastqsanger.gz
	ERR12719201_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 364

Similar Datasets

Exploring the microbiome of oral epithelial dysplasia as a predictor of malignant progression

Project description:The objectives of this study were to establish a microbiome profile for oral epithelial dysplasia using archival lesion swab samples to characterize the community variations and the functional potential of the microbiome using 16S rRNA gene sequencing

2022-09-30 | GSE198811 | GEO

The Dynamics of the Vaginal Microbiome During Infertility Therapy with In Vitro Fertilization-Embryo Transfer

Project description:Clinical treatment protocols for infertility with in vitro fertilization-embryo transfer (IVF-ET) provide a unique opportunity to assess the human vaginal microbiome in defined hormonal milieu. Herein, we have investigated the association of circulating ovarian-derived estradiol (E2) and progesterone (P4) concentrations to the vaginal microbiome. Thirty IVF-ET patients were enrolled in this study, after informed consent. Blood was drawn at four time points during the IVF-ET procedure. In addition, if a pregnancy resulted, blood was drawn at 4-to-6 weeks of gestation. The serum concentrations of E2 and P4 were measured. Vaginal swabs were obtained in different hormonal milieu. Two independent genome-based technologies (and the second assayed in two different ways) were employed to identify the vaginal microbes. The vaginal microbiome underwent a transition with a decrease in E2 (and/or a decrease in P4). Novel bacteria were found in the vagina of 33% of the women undergoing IVF-ET. Our approach has enabled the discovery of novel, previously unidentified bacterial species in the human vagina in different hormonal milieu. While the relationship of hormone concentration and vaginal microbes was found to be complex, the data support a shift in the microbiome of the human vagina during IVF-ET therapy using standard protocols. The data also set the foundation for further studies examining correlations between IVF-ET outcome and the vaginal microbiome within a larger study population.

2011-10-24 | E-MEXP-2958 | biostudies-arrayexpress

Project description:Vaginal Microbiome from healthy and cervical cancer women

| PRJNA1025964 | ENA

Exploring the clinical signatures of cervical dysplasia patients and their association with vaginal microbiota

Project description:Exploring the clinical signatures of cervical dysplasia patients and their association with vaginal microbiota

| PRJEB63139 | ENA

Microbiome features of bronchopulmonary dysplasia

Project description:Microbiome features of bronchopulmonary dysplasia

| PRJNA1105631 | ENA

Human Pap test LC-MS/MS metaproteomics

Project description:The human cervical-vaginal area contains proteins derived from microorganisms that may prevent or predispose women to gynecological conditions. The liquid Pap test fixative is an unexplored resource for analysis of microbial communities and the microbe-host interaction. Previously, we showed that the residual cell-free fixative from discarded Pap tests of healthy women could be used for mass spectrometry (MS) based proteomic identification of cervical-vaginal proteins. In this study, we reprocessed these MS raw data files for metaproteomic analysis to characterize the microbial community composition and function of microbial proteins in the cervical-vaginal region. This was accomplished by developing a customized protein sequence database encompassing microbes likely present in the vagina. High-mass accuracy data were searched against the protein FASTA database using a two-step search method within the Galaxy for proteomics platform. Data was analyzed by MEGAN6 (MetaGenomeAnalyzer) for phylogenetic and functional characterization. We identified over 300 unique peptides from a variety of bacterial phyla and Candida. Peptides corresponding to proteins involved in carbohydrate metabolism, oxidation-reduction, and transport were identified. By identifying microbial peptides in Pap test supernatants it may be possible to acquire a functional signature of these microbes, as well as detect specific proteins associated with cervical health and disease.

2018-07-23 | PXD009596 | Pride

Dried human cervico vagnial fluid on FTA-cards LC-MS/MS

Project description:Cervical cancer is the fourth most common cancer among women worldwide and screening pro-grams increase detection rate and survivability. Molecular screening of presence of human papil-loma viruses (HPV) as alternatives to physical examinations offers cost-efficient solutions and can be performed on self-collected samples. A persistent infection with HPV is necessary but not sufficient to develop cancer and additional biomarkers are needed to increase the precision. We have analyzed protein biomarkers found in self-collected dried cervico-vaginal fluid (CVF) from both controls and women with cervical cancer pre-stages.

2022-02-17 | PXD026064 | Pride

Cervical Tissue Long SAGE

Project description:16 Long SAGE libraries Keywords: Various degrees of cervical dysplasia Normal Cervical Tissue (N1, N2, N3, N4) CIN III, severe dysplasia cervical tissue (C1, C2, C3, C4, C5, C6) CIN I, mild dysplasia, cervical tissue (M1, M2, M3) CIN II, moderate dysplasia, cervical tissue (M4, M5, M6)

2008-02-18 | E-GEOD-7433 | biostudies-arrayexpress

Project description:vaginal microbiome and cervical cancer

| PRJNA771720 | ENA

Project description:cervical cancer and vaginal microbiome

| PRJNA687644 | ENA